0

BMS-309403

INQUIRY Add to cart
For Research Use Only | Not For Clinical Use
CATAP300657038
CAS300657-03-8
Structure
MDL NumberMFCD09991687
Molecular Weight474.55
Description≥98% (HPLC)
SolubilityDMSO: 10 mg/mL, clear
Assay≥98% (HPLC)
Colorwhite to beige
Formpowder
Size5MG, 25MG
Storage Conditionsroom temp
1

Crystallographic Study of FABP5 as an Intracellular Endocannabinoid Transporter

Benoît Sanson, Tao Wang, Jing Sun, Liqun Wang, Martin Kaczocha, Iwao Ojima, Dale Deutsch, Huilin Li

Acta Crystallogr D Biol Crystallogr. 2014 Feb;70(Pt 2):290-8.

PMID: 24531463

1

Effect of Fill Weight, Capsule Shell, and Sinker Design on the Dissolution Behavior of Capsule Formulations of a Weak Acid Drug Candidate BMS-309403

Yongmei Wu, Fang Zhao, Mehdi Paborji

Pharm Dev Technol. 2003;8(4):379-83.

PMID: 14601962

1

Effects of Host Fatty Acid-Binding Protein 4 on Eimeria Tenella Sporozoites Invasion of Cells

Lu Wang, Shunhai Zhu, Qiping Zhao, Bing Huang, Ling Lv, Guiling Liu, Zhihang Li, Huanzhi Zhao, Hongyu Han, Hui Dong

Parasitol Res. 2019 Jun;118(6):1919-1926.

PMID: 31069534

1

Synthesis of BMS-309403-related Compounds, Including [¹⁴C]BMS-309403, a Radioligand for Adipocyte Fatty Acid Binding Protein

Toshihiko Okada, Makoto Hiromura, Masato Otsuka, Shuichi Enomoto, Hiroyuki Miyachi

Chem Pharm Bull (Tokyo). 2012;60(1):164-8.

PMID: 22223390

1

Vasculo-protective Effect of BMS-309403 Is Independent of Its Specific Inhibition of Fatty Acid-Binding Protein 4

Yuta Okamura, Kosuke Otani, Akihiro Sekiguchi, Taisuke Kogane, Chiharu Kakuda, Yuzaburo Sakamoto, Tomoko Kodama, Muneyoshi Okada, Hideyuki Yamawaki

Pflugers Arch. 2017 Sep;469(9):1177-1188.

PMID: 28405802

  • Verification code
Contact Us

Send Us a Request

What is your specific need? We will do everything we can to meet your expectations.
Online Inquiry

Online Inquiry

For any inquiry, question or recommendation, please call: or fill out the following form.

  • Verification code

Head Office

  • Tel:
  • Email:

Follow us on

qrcode